Moolec Science SA (NASDAQ:MLEC)
| Market Cap | 1.60M-82.1% |
| Revenue (ttm) | 7.83M+170.4% |
| Net Income | -8.28M-27.8% |
| EPS | -3.30-27.0% |
| Shares Out | 726.12K |
| PE Ratio | n/a |
| Forward PE | 0.07 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 171,634 |
| Open | 3.93 |
| Previous Close | 4.19 |
| Day's Range | 1.99 - 4.42 |
| 52-Week Range | 1.99 - 23.22 |
| Beta | 0.26 |
| Analysts | Buy |
| Price Target | 45.00(+1945.45%) |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About MLEC
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
$MLEC stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in MLEC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MLEC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MLEC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
MLEC Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New MLEC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MLEC from public contracts
Source: USAspending.gov
MLEC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MLEC’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.